JLL has decided to set up a Life Sciences team in France. At the same time, the corporate real estate consultancy has also joined (...)
Remake is expanding its portfolio in Spain with the acquisition of three buildings through two sale & leasebacks in Catalonia and the Basque Country (...)
Life Sciences real estate - an asset class that encompasses the infrastructure occupied by the pharmaceutical, biotechnology and medical industries - has established itself (...)
Business Immo Global: Can we conclude from the successful fundraising of the Blackstone Real Estate Partners X fund that institutional investors still have a (...)
Business Immo: Faced with strong macroeconomic and geopolitical tensions, real estate investors must now deal with a new financial context. How do you interpret (...)
After completing its first French acquisition in Villejuif at the end of 2022, Kadans Sciences Partners announced in mid-February its second French project, this (...)
Business Immo: Aviva Investors is rebuilding its presence in France following the sale of Aviva France in the fall of 2021. Where are you (...)
After making its first real estate acquisition in France last year*, Kadans Science Partner has just signed a promise of sale with the EPA (...)
Some courageous investors and advisors have spoken out since last December and have given us their vision of the markets in which they operate. (...)
The "jewel of Romainville" has finally found a new taker. Oxford Properties and Novaxia announced this Thursday the acquisition from Fiminco and Banque des (...)
Business Immo: This time, the page of the Duo towers, inaugurated at the beginning of the fall, is definitively turned? Karim Habra: The construction is (...)
Through a co-investment partnership involving €1bn of capital, Novaxia and Oxford Properties have acquired a €2bn investment capacity to be deployed between now and (...)
As part of a co-investment partnership, Novaxia and Oxford Properties intend to raise €1bn of capital in France by 2024 for Life Sciences real (...)
BiTV Interviews welcomes Michel Leemhuis, CEO and Co-owner at Kadans Science Partner. With him, we discuss the new 70,000 sqm building in London developped by his (...)
AXA IM Alts raised a record €18.2bn of capital in 2021, including €10.2bn of third party commitments, reflecting the strong positioning and suitability of (...)
Paris-based global manager AXA IM Alts has raised €1.9bn of equity to accelerate investments into the Life Sciences sector. The capital raised will primarily (...)
© Business Immo 2023 CoStar Group
